Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.8, 2000-08, pp. : 1787-1796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on antifungals targeted to the cell wall: focus on &bgr;-1,3-glucan synthase inhibitors

By Georgopapadakou N.H.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 269-280

Informa Healthcare

Access to resources Recommend Favorite

Antifungals targeted to protein modification: focus on protein N-myristoyltransferase

By Georgopapadakou Nafsika H

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 8, 2002-08 ,pp. : 1117-1125

Informa Healthcare

Access to resources Recommend Favorite

Antifungals targeted to the cell wall

By Georgopapadakou N.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 2, 1997-02 ,pp. : 147-150

Informa Healthcare

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 1986-2001

Bentham Science Publishers

Access to resources Recommend Favorite

Lithium Pharmacodynamics and Pharmacogenetics: Focus on Inositol Mono Phosphatase (IMPase), Inositol Poliphosphatase (IPPase) and Glycogen Sinthase Kinase 3 Beta (GSK-3 Beta)

Current Medicinal Chemistry, Vol. 16, Iss. 15, 2009-05 ,pp. : 1917-1948

Bentham Science Publishers

Access to resources Recommend Favorite